BCIQ Profiles

Company Profile ReportTarget Profile Report
DIST_0616_scitranslmed.aax4100

An optimized version of the discontinued EGFRvIII-targeting GBM vaccine candidate Rintega

Jul 2, 2021 | 11:16 PM GMT

DISEASE CATEGORY: Cancer

INDICATION: Brain cancer

Introducing a G6Y amino acid substitution

Read the full 266 word article

How to gain access

Continue reading with a
two-week free trial.